Our observation that intermediate monocytes (CD14+CD16+) with CD11c+ and HLA-DR+ expression correlation with the amount of macrophages from the lung cancer microenvironment may indicate role a of these cells in cancer immunity. The gene discussed is CD14; the disease is lung carcinoma.